PB
BEAM icon

Pinnacle Bancorp’s Beam Therapeutics BEAM Stock Holding History

Pinnacle Bancorp’s Portfolio BEAM Stock Details BEAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-97
Closed -$2.35K – 878
2025
Q3 		$2.35K Hold
97
– – ﹤0.01% 871
2025
Q2 		$1.65K Hold
97
– – ﹤0.01% 878
2025
Q1 		$1.89K Hold
97
– – ﹤0.01% 857
2024
Q4 		$2.41K Hold
97
– – ﹤0.01% 845
2024
Q3 		$2.38K Hold
97
– – ﹤0.01% 840
2024
Q2 		$2.27K Hold
97
– – ﹤0.01% 817
2024
Q1 		$3.21K Hold
97
– – ﹤0.01% 776
2023
Q4 		$2.64K Hold
97
– – ﹤0.01% 764
2023
Q3 		$2.33K Hold
97
– – ﹤0.01% 748
2023
Q2 		$3.1K Hold
97
– – ﹤0.01% 724
2023
Q1 		$2.97K Buy
+97
New +$3.83K ﹤0.01% 752

Other funds holding BEAM

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Pinnacle Bancorp's BEAM Position: Q4 2025 in Review

Pinnacle Bancorp sold out of Beam Therapeutics (BEAM) in Q4 2025, closing a stake of 97 shares — an estimated $2.35K sold.

Pinnacle Bancorp first reported a position in BEAM in Q1 2023 and held it in 11 quarters. The position peaked at $3.21K in Q1 2024. 246 funds tracked by Wall St. Rank hold BEAM as of Q4 2025.

  • Pinnacle Bancorp reported no remaining Beam Therapeutics position as of Q4 2025 after selling out during the quarter.
  • Pinnacle Bancorp sold 97 Beam Therapeutics shares in Q4 2025, an estimated $2.35K.
  • Pinnacle Bancorp first reported a position in Beam Therapeutics in Q1 2023 and held it in 11 quarters.
  • Pinnacle Bancorp's Beam Therapeutics position peaked at $3.21K in Q1 2024.
  • 246 funds tracked by Wall St. Rank held Beam Therapeutics as of Q4 2025.

Based on Pinnacle Bancorp's 13F filing for Q4 2025, filed 22 Jan 2026.